Latest Vietnam News

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

RLF AgTech's second-year durian trial in Vietnam confirms a 38% yield increase and significant plant growth improvements, suggesting a potential 10-fold return on investment with minimal cost rise.

Paragon Care Limited is set to acquire Indonesian medical aesthetics leader Haju Medical for A$70 million, aiming to boost its footprint across Asia Pacific and accelerate growth in the aesthetics sector.

TruScreen Group Limited reported a 17% decline in first half FY2026 product sales but affirmed full-year revenue guidance at NZ$2.8 million, supported by strategic expansions and a successful NZ$4 million capital raise.

SPC Global Holdings delivered a transformational FY25 with robust financial results and strategic international growth, setting the stage for a confident 25% EBITDA increase in FY26.

Critica Limited has demonstrated a 63% recovery of gallium oxide as a valuable by-product from its vast Jupiter rare earth deposit in Western Australia, integrating seamlessly into its existing beneficiation flowsheet. This milestone enhances the project’s strategic value amid global supply chain tensions.

First Graphene has completed its initial industrial-scale shipment of graphene-enhanced TPU masterbatch to PT Alasmas, marking a key milestone in commercialising advanced materials for durable work boots in Southeast Asia.

BlueScope has appointed Tania Archibald as its new Managing Director and CEO, succeeding Mark Vassella who retires after eight years. Archibald’s extensive internal experience positions her to lead the company’s next strategic phase.

WA Kaolin Ltd has reported a record-breaking quarter in sales volume and revenue, driven by operational enhancements and expanding market reach across Asia and domestic sectors.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

Osteopore Limited reported a 7% year-on-year revenue increase in Q3 CY25, secured Swiss market approval for its implants, and saw a threefold sales surge through its Zimmer Biomet partnership.

WA Kaolin Limited has reported a remarkable surge in sales volumes and revenue for the September 2025 quarter, driven by operational upgrades and expanding market reach. The company’s forward orders and product diversification signal robust growth ahead.